These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Replacement therapy with blood components in bone-marrow depression due to cytostatic drugs (author's transl)]. Höcker P; Pittermann E; Mann M; Krasa E Wien Klin Wochenschr; 1980 Aug; 92(15):530-5. PubMed ID: 7001766 [TBL] [Abstract][Full Text] [Related]
45. [Warm hemolytic anemia from the aspect of transfusion medicine]. Haspl ZH Lijec Vjesn; 2007 May; 129 Suppl 3():11-3. PubMed ID: 18959052 [No Abstract] [Full Text] [Related]
46. When should we use blood or blood components? Knouse CA J Am Osteopath Assoc; 1977 Apr; 76(8):633, 635-9 concl. PubMed ID: 408391 [No Abstract] [Full Text] [Related]
47. Transfusion requirements of the leukemic patient. Wheeler JT Tex Med; 1981 Aug; 77(8):58-9. PubMed ID: 7268647 [No Abstract] [Full Text] [Related]
48. Changing trends in the use of blood transfusions. Hollán Z Ther Hung; 1986; 34(2):74-83. PubMed ID: 3449972 [No Abstract] [Full Text] [Related]
49. Modern principles of blood transfusion therapy. Wallas CH; Panlilio AL; Jenkins DE J Tenn Med Assoc; 1978 Sep; 71(9):651-8. PubMed ID: 703308 [No Abstract] [Full Text] [Related]
50. [Role of immunologic reactions in the development, prevention and treatment of postoperative anemia]. Dmitrieva VA; Samsonova NN; Samuilova DSh Vestn Khir Im I I Grek; 1983 Dec; 131(12):91-7. PubMed ID: 6670177 [TBL] [Abstract][Full Text] [Related]
53. Red cell transfusion problems in immunohematologic disease. Petz LD Annu Rev Med; 1982; 33():355-61. PubMed ID: 7081965 [No Abstract] [Full Text] [Related]
54. The blood components--advancement in haemotherapy. Nathan IV; Han P J Singapore Paediatr Soc; 1986; 28(3-4):216-26. PubMed ID: 3599928 [No Abstract] [Full Text] [Related]
55. Blood component therapy in the perinatal period: guidelines and recommendations. DePalma L; Luban NL Semin Perinatol; 1990 Oct; 14(5):403-15. PubMed ID: 2126893 [No Abstract] [Full Text] [Related]
56. Pooled platelet concentrates and the quality of the red blood cell supply. Zimmermann R; Weiss DR; Zingsem J; Ringwald J; Eckstein R Clin Lab; 2012; 58(1-2):1-6. PubMed ID: 22372340 [No Abstract] [Full Text] [Related]
57. Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease. Noizat-Pirenne F; Bachir D; Chadebech P; Michel M; Plonquet A; Lecron JC; Galactéros F; Bierling P Haematologica; 2007 Dec; 92(12):e132-5. PubMed ID: 18055978 [TBL] [Abstract][Full Text] [Related]
58. Primary biliary cirrhosis associated with mixed type autoimmune hemolytic anemia and sicca syndrome: a case report and review of literature. Chen CY; Lu CL; Chiu CF; Chang FY; Lee SD Am J Gastroenterol; 1997 Sep; 92(9):1547-9. PubMed ID: 9317084 [TBL] [Abstract][Full Text] [Related]
59. [Therapy with erythrocyte sediments]. Hasse W Hamatol Bluttransfus; 1968; 5():8-19. PubMed ID: 5729468 [No Abstract] [Full Text] [Related]